Atorvastatin effects on blood viscosity
Pro Research Analysisby 
Searched over 200M research papers
Atorvastatin and Blood Viscosity: Key Effects in Different Patient Populations
Blood Viscosity Reduction in Hypertriglyceridemia and Hyperlipidemia
Atorvastatin has been shown to significantly reduce blood viscosity in patients with hypertriglyceridemia and hyperlipidemia. In hypertriglyceridemic patients, a daily dose of 10 mg atorvastatin for four weeks led to a 16% reduction in blood viscosity at low shear rates and a 2% reduction in plasma viscosity, alongside improvements in LDL cholesterol and LDL subfraction profiles . Similar effects were observed in patients with familial hypercholesterolemia, where atorvastatin reduced whole blood viscosity, plasma viscosity, and red cell aggregation, even in those already receiving LDL apheresis . These improvements in blood flow properties may contribute to the cardiovascular benefits of atorvastatin in patients with severe lipid disorders .
Hemorheological Improvements in Coronary Heart Disease and Diabetic Nephropathy
In patients with coronary heart disease and angina pectoris, atorvastatin—alone or combined with other agents like metoprolol or propyl gallate—significantly lowered plasma viscosity, whole blood viscosity, hematocrit, and fibrinogen levels, indicating improved hemodynamics and blood flow Wang2017Liu2019. These changes were associated with better clinical outcomes and reduced inflammatory markers Wang2017Liu2019. In diabetic nephropathy, atorvastatin treatment for three months led to significant decreases in whole blood viscosity, erythrocyte aggregation, and fibrinogen, as well as improvements in renal function and inflammation .
Combination Therapies and Enhanced Effects
Combining atorvastatin with other medications, such as folic acid or amlodipine, further enhanced its effects on blood viscosity and vascular health. In patients with hyperlipidemia and cerebral infarction, atorvastatin plus folic acid reduced whole blood viscosity, plasma viscosity, and hematocrit more than atorvastatin alone . Similarly, in hypertensive patients with atherosclerosis, atorvastatin combined with amlodipine led to greater reductions in whole blood and plasma viscosity, as well as improved endothelial function and immune balance .
Consistent Findings Across Studies
Across various patient groups—including those with hypertriglyceridemia, familial hypercholesterolemia, coronary heart disease, diabetic nephropathy, and cerebral infarction—atorvastatin consistently improved blood rheology by lowering blood and plasma viscosity, reducing red cell aggregation, and decreasing fibrinogen levels Empen2003Banyai2001Wang2017+4 MORE. These effects were often accompanied by improvements in lipid profiles and reductions in inflammatory markers.
Conclusion
Atorvastatin effectively reduces blood viscosity and improves hemorheological parameters in a range of cardiovascular and metabolic conditions. These benefits are observed both as monotherapy and in combination with other agents, supporting its role in improving blood flow and potentially reducing cardiovascular risk in patients with lipid disorders and related diseases Empen2003Banyai2001Wang2017+4 MORE.
Sources and full results
Most relevant research papers on this topic
Effects of atorvastatin calcium tablets combined with betaloc on angina pectoris of coronary heart disease, blood lipid level and hemodynamics
Atorvastatin calcium tablets combined with betaloc effectively reduce blood lipid levels, improve hemodynamics, and alleviate inflammation in patients with angina pectoris of coronary heart disease.
DOI
Atorvastatin calcium tablets on inflammatory factors, hemorheology and renal function damage indexes in patients with diabetic nephropathy
Atorvastatin effectively alleviates renal function damage, reduces serum inflammatory factors, and improves hemorheology in diabetic nephropathy patients.
Propyl gallate injection combined with atorvastatin in treatment of patients with coronary heart disease and hyperlipidemia
Propyl gallate injection combined with atorvastatin effectively improves blood lipid levels, blood rheology indicators, and vascular endothelial function in patients with coronary heart disease and hyperlipidemia, with high safety.
DOI